Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Repligen: Revenues For 2014 Are Above Expectations And Guidance For 2015 Is For Strong Growth (RGEN, Hold/ Buy, $23.84)

Repligen has reported that 2014 product revenues were above expectations and issued strong sales guidance for 2015. The stock was up 20% on the news. See my website report for more details. You don't need to be a subscriber to access this report.

Disclosure: The author is long RGEN.